Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer
NCT ID: NCT00581503
Last Updated: 2022-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2007-03-31
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optical Coherence Tomography in Staging Patients With Upper Tract Urothelial Cancer
NCT02108587
Transrectal Photoacoustic Imaging of the Prostate
NCT02365883
Verification of Shear Wave Elastography for DEtection of Prostate Cancer
NCT04836949
Transurethral Ultrasonic Imaging For Detection and Classification of Prostate Cancer
NCT02307552
Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer
NCT01688414
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
diagnostic
oct imaging
diagnostic
oct imaging
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
diagnostic
oct imaging
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having procedure of endobronchial, transbronchial, and / or pleural biopsy
Exclusion Criteria
* Currently taking drugs that are sensitive to light.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beckman Laser Institute University of California Irvine
OTHER
University of California, Irvine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beckman Laser Institute and Medical Center
Matthew Brenner, M.D.,Department of Pulmonary and Critical Care Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthew Brenner, M.D
Role: PRINCIPAL_INVESTIGATOR
Beckman Laser Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pulmonary and Critical Care Medicine, UCI Medical Center
Orange, California, United States
Urology department, UCI Medical Center
Orange, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20064981
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.